Lipid N2-3L

Catalog No.: A76257
Cationic Liposome
Lipid N2-3L is an ionizable cationic lipid (pKa = 8.99) designed for the formation of supramolecular lipid nanoparticles (SMLNPs), facilitating mRNA delivery. Research demonstrates its ability to effectively deliver encapsulated genetic materials, such as luciferase reporter genes, which accumulate in lymph nodes, indicating robust entry into the immune system. Additionally, Lipid N2-3L has shown potential in cancer therapy, evidenced by its capacity to reduce tumor volume and enhance survival in an MC-38-OVA mouse colon cancer model when used alongside ovalbumin mRNA and the TLR7/8 agonist Resiquimod. This lipid is a valuable tool for advancing research in targeted drug delivery for cancer therapies.
Grouped product items
Size Stock
5mg
10mg
50mg
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionLipid N2-3L is an ionizable cationic lipid (pKa = 8.99) designed for the formation of supramolecular lipid nanoparticles (SMLNPs), facilitating mRNA delivery. Research demonstrates its ability to effectively deliver encapsulated genetic materials, such as luciferase reporter genes, which accumulate in lymph nodes, indicating robust entry into the immune system. Additionally, Lipid N2-3L has shown potential in cancer therapy, evidenced by its capacity to reduce tumor volume and enhance survival in an MC-38-OVA mouse colon cancer model when used alongside ovalbumin mRNA and the TLR7/8 agonist Resiquimod. This lipid is a valuable tool for advancing research in targeted drug delivery for cancer therapies.
Product Information
Catalog NumA76257
FormulaC48H93N3O8
Molecular Weight840.27
CAS Number2924606-55-1
SMILESOCCN(CCO)CCCNC(OCCN(CCOC(CCCCCCC/C=C\CCCCCCCC)=O)CCOC(C(CCCCCC)CCCCCCCC)=O)=O
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2